363 related articles for article (PubMed ID: 10644308)
1. Immunohistochemical analysis of the distribution of measles related antigen in the intestinal mucosa in inflammatory bowel disease.
Iizuka M; Chiba M; Yukawa M; Nakagomi T; Fukushima T; Watanabe S; Nakagomi O
Gut; 2000 Feb; 46(2):163-9. PubMed ID: 10644308
[TBL] [Abstract][Full Text] [Related]
2. Detection of immunoreactive antigen, with a monoclonal antibody to measles virus, in tissue from a patient with Crohn's disease.
Miyamoto H; Tanaka T; Kitamoto N; Fukuda Y; Shimoyama T
J Gastroenterol; 1995 Feb; 30(1):28-33. PubMed ID: 7719411
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects.
Rüthlein J; Ibe M; Burghardt W; Mössner J; Auer IO
Gut; 1992 Apr; 33(4):507-12. PubMed ID: 1582596
[TBL] [Abstract][Full Text] [Related]
4. Detection and comparative analysis of persistent measles virus infection in Crohn's disease by immunogold electron microscopy.
Daszak P; Purcell M; Lewin J; Dhillon AP; Pounder RE; Wakefield AJ
J Clin Pathol; 1997 Apr; 50(4):299-304. PubMed ID: 9215145
[TBL] [Abstract][Full Text] [Related]
5. Cellular hypersensitivity to components of intestinal mucosa in ulcerative colitis and Crohn's disease.
Bendixen G
Gut; 1969 Aug; 10(8):631-6. PubMed ID: 5810973
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatic and immunological analysis reveals lack of support for measles virus related mimicry in Crohn's disease.
Polymeros D; Tsiamoulos ZP; Koutsoumpas AL; Smyk DS; Mytilinaiou MG; Triantafyllou K; Bogdanos DP; Ladas SD
BMC Med; 2014 Aug; 12():139. PubMed ID: 25168804
[TBL] [Abstract][Full Text] [Related]
7. Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls.
Kusugami K; Youngman KR; West GA; Fiocchi C
Gastroenterology; 1989 Jul; 97(1):1-9. PubMed ID: 2785943
[TBL] [Abstract][Full Text] [Related]
8. Measles is more prevalent in Crohn's disease patients. A multicentre Israeli study.
Lavy A; Broide E; Reif S; Keter D; Niv Y; Odes S; Eliakim R; Halak A; Ron Y; Patz J; Fich A; Villa Y; Arber N; Gilat T
Dig Liver Dis; 2001; 33(6):472-6. PubMed ID: 11572573
[TBL] [Abstract][Full Text] [Related]
9. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease.
Kusugami K; Matsuura T; West GA; Youngman KR; Rachmilewitz D; Fiocchi C
Gastroenterology; 1991 Dec; 101(6):1594-605. PubMed ID: 1683326
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease.
Walmsley RS; Zhao MH; Hamilton MI; Brownlee A; Chapman P; Pounder RE; Wakefield AJ; Lockwood CM
Gut; 1997 Jan; 40(1):105-9. PubMed ID: 9155585
[TBL] [Abstract][Full Text] [Related]
11. Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease.
Allison MC; Cornwall S; Poulter LW; Dhillon AP; Pounder RE
Gut; 1988 Nov; 29(11):1531-8. PubMed ID: 3209109
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease.
Rosenberg WM; Prince C; Kaklamanis L; Fox SB; Jackson DG; Simmons DL; Chapman RW; Trowell JM; Jewell DP; Bell JI
Lancet; 1995 May; 345(8959):1205-9. PubMed ID: 7537840
[TBL] [Abstract][Full Text] [Related]
13. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
14. IgM antibody against measles virus in patients with inflammatory bowel disease: a marker of virus-related disease?
Balzola FA; Castellino F; Colombatto P; Manzini P; Astegiano M; Verme G; Brunetto MR; Pera A; Bonino F
Eur J Gastroenterol Hepatol; 1997 Jul; 9(7):661-3. PubMed ID: 9262973
[TBL] [Abstract][Full Text] [Related]
15. Measles IgM immunoreactivity in patients with inflammatory bowel disease.
Balzola FA; Khan K; Pera A; Bonino F; Pounder RE; Wakefield AJ
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):378-82. PubMed ID: 9789132
[TBL] [Abstract][Full Text] [Related]
16. Crohn's disease, ulcerative colitis, and normal intestinal lymphocytes express integrins in dissimilar patterns.
Yacyshyn BR; Lazarovits A; Tsai V; Matejko K
Gastroenterology; 1994 Nov; 107(5):1364-71. PubMed ID: 7523224
[TBL] [Abstract][Full Text] [Related]
17. Emergence of antigenic glycoprotein structures in ulcerative colitis detected through monoclonal antibodies.
Podolsky DK; Fournier DA
Gastroenterology; 1988 Aug; 95(2):371-8. PubMed ID: 2455670
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease.
Seibold F; Weber P; Jenss H; Wiedmann KH
Gut; 1991 Oct; 32(10):1192-7. PubMed ID: 1955175
[TBL] [Abstract][Full Text] [Related]
19. Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163.
Demetter P; De Vos M; Van Huysse JA; Baeten D; Ferdinande L; Peeters H; Mielants H; Veys EM; De Keyser F; Cuvelier CA
Ann Rheum Dis; 2005 Feb; 64(2):321-4. PubMed ID: 15166002
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]